Era | Author | Subgroup | Year | Study design | Patients | Total complication | CVA | CT | Acute AI | MI | Vascular* |
---|---|---|---|---|---|---|---|---|---|---|---|
No TAVI (pre-2002) | NHLBI Registry18 | NA | 1991 | MC, R | 674 | 25% | 2% | 1% | 1% | NA | 34% |
Mansfield Registry19 20 | NA | 1991 | MC, P | 492 | 21% | 2% | 2% | 1% | NA | NA | |
Lieberman et al41 | NA | 1995 | SC | 165 | NA | 0.4% | NA | 1.1% | NA | NA | |
TAVI (2002 to current) | Agarwal et al42 | NA | 2005 | SC, R | 212 | NA | 0.4% | NA | 1.1% | NA | 13.5% |
Klein et al43 | NA | 2006 | SC, R | 78 | 22% | 1% | 1% | 0% | 1% | NA | |
Tissot et al21 | NA | 2011 | SC, P | 253 | 4% | 0% | NA | 0% | 0% | 1% | |
Khawaja et al15 | NA | 2013 | MC | 423 | 6.3% | 1% | 1% | NA | 1% | 2.2% | |
Ben-Dor et al22 | NA | 2013 | SC, P | 472 | NA | 2% | 1% | 1% | 0% | 11% | |
Saia et al10 | NA | 2013 | SC, R | 415 | NA | 1% | NA | 2.6% | 0% | 5.6% | |
Eltchaninoff et al44 | NA | 2014 | SC, R | 323 | 7% | 2% | 0% | 2% | 0% | 2.5% | |
Moretti et al23 | Dest. | 2015 | MC, R | 416 | NA | 0.8% | NA | NA | 2.4% | 11%† | |
B-TAVI | 320 | NA | 0.7% | NA | NA | 0.8% | 7.7%† | ||||
B-AVR | 75 | NA | 0% | NA | NA | 0% | 12%† |
*Includes both major and minor vascular complications as well as requirement for blood transfusions.
†According to VARC criteria.
AI, aortic insufficiency; BAV, balloon aortic valvuloplasty; B-AVR, bridge to aortic valve; B-TAVI, bridge to TAVI; CT, cardiac tamponade; CVA, cerebrovascular accident; Dest, destination therapy; MC, multicentre; MI, myocardial infarction; NA, not available; NHLBI, National Heart Lung and Blood Institute; P, prospective; R, retrospective; SC, single-centre; TAVI, transcatheter aortic valve implantation; VARC, Valve Academic Research Consortium Definitions.